NIH-funded research R21 grant

Investigating how HIV affects lung bacteria and inflammation

Official title: HIV-induced microbial alterations and inflammation in the lung of humanized mice

Funded at Washington University · NIH-11115658 · Data updated 2026-11-12

This study is looking at how HIV affects the bacteria in the lungs and causes inflammation, using special mice that have human-like immune systems, to help find ways to improve lung health for people living with HIV.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJune 13, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$194,375
NIH project number5R21AI181675-02
Project IDNIH-11115658 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are on antiretroviral therapy and may be experiencing lung-related health issues.

Less likely to help

Patients who are not living with HIV or those who do not have any lung-related complications may not benefit from this research.

What this research studies

This research explores the impact of HIV on the lung microbiome and inflammation in a controlled animal model. By using humanized mice, the study aims to understand how HIV alters the bacteria present in the lungs and how these changes contribute to chronic lung diseases. The researchers will monitor the dynamics of lung inflammation and microbial changes over time, providing insights into the mechanisms that may lead to complications in people living with HIV. This approach could help identify potential therapeutic targets for improving lung health in these patients.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating chronic lung diseases in individuals living with HIV.

How similar studies have gone: Previous studies have indicated that understanding the lung microbiome in HIV-positive individuals can provide valuable insights, suggesting that this research could build on existing knowledge.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Shan, Liang — Washington University
  • Study coordinator: Shan, Liang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.